MSD (France)

Recent papers from MSD (France)

1. Bacterial epidemiology and attributable mortality of Ventilator-associated pneumonia before and after COVID-19 pandemic (2018-2021)Journal of Intensive Care Medicine · 2026
2. A seven-valent norovirus mRNA vaccine elicits robust humoral responses in preclinical modelsJournal of Virology · 2026
3. Clinical Phenotyping of Atopic Dermatitis Using Combined Global Severity (POEM) and Facial Burden (BoFA): A French Population-based Observational StudyActa Dermato Venereologica · 2026
4. Changes in effectiveness and safety in patients with Lennox–Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open‐label extension studyEpilepsia Open · 2026
5. Prolonged fenfluramine use in open‐label studies of Dravet or Lennox–Gastaut syndromes: Long‐term safety, tolerability, patient global functioning, and considerations for interpreting effectivenessEpilepsia · 2026
6. Comparison of under-mattress sensor and CPAP data for home monitoring in obstructive sleep apneaSleep And Breathing · 2026
7. Healthcare resource utilization and persistence in children and adults with Dravet syndrome receiving fenfluramine: a retrospective analysis using United States claims dataSeizure · 2026
8. Association Between Bimekizumab’s Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and IIDermatology and Therapy · 2026
9. The Path to Future‐Proof Photovoltaics in Europe: Current Status and Impact of Technological Innovation on Reliable and Bankable PhotovoltaicsAdvanced Energy and Sustainability Research · 2026
10. 688P Equitable nationwide access to innovation in oncology: Real-world implementation of the French early access program for pembrolizumab in early triple-negative breast cancerESMO Open · 2026
11. Real-world use of letermovir for CMV prevention in allogeneic hematopoietic cell transplantation recipients in France: a national claims database studyFrontiers in Virology · 2026
12. Vaccines as Global Health Security Infrastructure: Insights from a Descriptive Analysis of Vaccines Europe Members’ Clinical PipelinesVaccines · 2026
13. A community programme of home visits by dieticians after discharge from geriatric acute care wards: baseline characteristics according to weight change during follow-upBMC Geriatrics · 2026
14. Abstract PS2-02-09: Fr-pop: Real-world data from 7,687 high-risk TNBC patients treated with perioperative pembrolizumab in FranceClinical Cancer Research · 2026
15. Abstract PS2-06-20: Fr-popea: French real-world-data of peri-operative pembrolizumab KN522 regimen in extreme ages subgroups (<30 y.o and >70 y.o) with high-risk TNBCClinical Cancer Research · 2026
16. Democratizing profit‐with‐purpose corporations: Governance pluralism through new legal pathways from FranceEuropean Management Review · 2025
17. Doravirine Resistance Patterns Identified Through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical TrialsJAIDS Journal of Acquired Immune Deficiency Syndromes · 2025
18. Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE studyBMJ Open · 2025
19. A simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy managementResearch in Social and Administrative Pharmacy · 2025
20. Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in FranceInfectious Diseases and Therapy · 2025